Reduced CD166 expression in mesenchymal stromal cells from osteoarthritic donors

A. Jacobi, H. Friedrich, J. Rauh, C. Vater, K.-P. Günther & M. Stiehler
Objective: Osteoarthritis (OA) as a common degenerative joint disease denotes a major socioeconomic problem. Cell-based strategies for the therapy of a variety of musculoskeletal disorders have received increasing attention. In this context, multipotent mesenchymal stromal cells (MSCs) represent an[for full text, please go to the a.m. URL]